Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry

Neuroendocrinology Letters

Volumn 29, Issue 5, 2008, Pages 749-754

  Marešová, Věra ^a   Chadt, Jiří ^a,b   Nováková, Eva ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Analysis; Drugs; Drugs of abuse; Gas chromatography mass spectrometry; Screening

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPRAZOLAM; AMITRIPTYLINE; BOVINE SERUM ALBUMIN; BROMAZEPAM; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; COCAINE; CODEINE; DIAZEPAM; DOSULEPIN; EPHEDRINE; GUAIFENESIN; LEVOMEPROMAZINE; MIRTAZAPINE; MORPHINE; N METHYL N TRIMETHYLSILYLTRIFLUOROACETAMIDE; PHENOBARBITAL; TRAMADOL; TRIFLUOROACETAMIDE DERIVATIVE; UNCLASSIFIED DRUG; ZOLPIDEM;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; DRUG ABUSE; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SCREENING; HUMAN; LIQUID LIQUID EXTRACTION; MASS FRAGMENTOGRAPHY; QUANTITATIVE ANALYSIS;

EID: 57149128743     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Drummer OH (1999). Chromatographic screening techniques in systematic toxicological analysis. J Chromatogr B. 733: 27-45.
2. Georgov M, Ojanperä I, Vuori E (2003). Simultaneous screening for 238 drugs in blood by liquid chromatography-ionspray tandem mass spectrometry with multiple-reaction monitoring. J Chromatogr B. 795: 41-53.
3. Gunnar T, Mykkänen S, Ariniemi K, Lillsunde P (2004). Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. J Chromatogr B. 806: 205-219.
4. Ishida T, Kudo K, Inoue H, Tsuji A, Kojima T, Ikeda N (2006). Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography-mass spectrometry. J Anal Toxicol. 30:468-477.
5. Lillsunde P, Michelson L, Forsström T, Korte T, Schults E, Ariniemi K, et al. (1996). Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety. Forensic Sci Int. 77: 191-210.
6. Maresova V, Chadt J, editor Heesun Chung (2000a). Comparison of extraction methods for screening of spiked bovine serum for basic, neutral and acidic drugs by GC-MS. Proceedings of the 43 rd International Meeting of The International Association of Forensic Toxicologists (TIAFT) East meets west in forensic toxicology; 29.8.-2.9.2005; Seoul, Korea. p. 3-27.
7. Maresova V, Chadt J, Prikryl L (2000b). Simultaneous determination of amphetamine and amphetamine-like designer drugs in human urine by GC-MS. Neuro Endocrinol Lett. 27 (Suppl.2): 121-124.
8. Marquet P, Saint-Marcoux F, Gamble TN, Leblanc J C (2003). Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique. J Chromatogr B. 789: 9-18.
9. Maurer HH (1992). Systematic toxicological analysis of drugs and their metabolites by gas chromatography-mass spectrometry. Review. J Chromatogr. 580: 3-41.
10. Maurer HH (1999). Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control. Review. J Chromatogr B. 733: 3-25.
11. Maurer HH (2000 a). Screening procedure for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. Review. Comb Chem High Through Scree. 3: 467-480.
12. Maurer HH, Bickeboeller-Friedrich J (2000 b). Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as a part of modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry. J Anal Toxicol. 24: 340-347.
13. Maurer HH (2004). Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin Chem Lab Med. 42: 1310-1324.
14. Maurer HH, Peters FT (2005). Toward high-throughput drug screening using mass spectrometry. Ther Drug Monit. 27: 686-688.
15. Maurer HH (2006). Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control. J Mass Spectrom. 41: 1399-1413.
16. Maurer HH (2007). Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem. 388: 1315-1325.
17. Ondra P, Zednikova K, Valka I (2006). Detection and determination of abused hallucinogens in biological material. Neuro Endocrinol Lett. 27 (Suppl 2): 125-129.
18. Paterson S, Cordero R, Burlinson 5 (2004). Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography/ion trap mass spectrometry. J Chromatogr B. 813: 323-330.
19. Peters FT, Schafer 5, Staack RF, Kraemer T, Maurer HH (2003). Screening for and validated quantification of amphetamine-and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom. 38: 695-676.
20. Polettini A (1996). A simple automated procedure for the detection and identification of peaks in gas chromatography-mass spectrometry. Application to systematic toxicological analysis of drugs in whole human blood. J Anal Toxicol. 20: 579-586.
21. Polettini A (1999). Systematic toxicological analysis of drugs and poisons in biosamples by hyphenated chromatographic and spectroscopic techniques. Review. J Chromatogr B. 733: 47-63.
22. Pragst F, Herzler M, Erxleben BT (2004). Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD). Clin Chem Lab Med. 42: 1325-1340.
23. Saint-Marcoux F, Lachatre G, Marquet P (2003). Evaluation of an improved general unknown screening procedure using liquid chromatography-mass spectrometry by comparison with gas chromatography and high-performance liquid chromatography diode array detection. J Am Soc Mass Spectrom. 14: 14-22.
24. Strano-Rossi S, Molaioni F, Rossi F, Botre F (2005). Rapid screening of drugs of abuse and their metabolites by gas chromatography-mass spectrometry. Rapid Commun Mass Spectrom. 19: 1529-1535.
25. Valentova J, Horakova R, Pechova I, Okrouhlica L, Devinsky F (2006). Stereoselective determination of methadone and its main metabolite in serum and urine from methadone maintenance patients. Neuro Endocrinol Lett. 27 (Suppl 2): 130-133.
26. Venisse N, Marguet P, Duchoslav E, Dupuy J, Lachatre G (2003). A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry. J Anal Toxicol. 27: 7-14.
27. Weinmann W, Wiedemann A, Eppinger B, Renz M, Svoboda M (1999). Screening for drugs in serum by electrospray ionization/ collision-induced dissociation and library searching. J Am Soc Mass Spectrom. 10: 1028-1037.
28. Weinmann W, Renz M, Vogt S, Pollak S (2000). Automated solidphase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC-MS. Int J Leg Med. 113: 229-235.